![]() | Only 14 pages are availabe for public view |
Abstract Vitiligo is a skin disorder characterized by the destruction and / or inactivation of melanocytes, resulting in patches of depigmentation. It affects individuals of all ethnic origins with an estimated prevalence of 0.5% -1% of the world population. 20 to 30 percent of Vitiligo patients may have a family history of this disorder . Men and women are equally affected. It can develop at any age. However, it begins before the age of 20 in about half of cases. Any area of skin can be affected. However, the most common sites involved are the face, neck and scalp. Other common sites include the backs of hands, front of knees, and elbows. It is often symmetrical in that patches may appear on similar places on each arm or leg. In the areas of the scalp that are affected, the hair too is affected causing it to become grey or white. Vitiligo is a multifactorial polygenic disorder with a complex pathogenesis. It is related to both genetic and nongenetic factors. Although several theories have been proposed about the pathogenesis of vitiligo, the precise cause remains unknown. Theories regarding vitiligo include autoimmune mechanisms, cytotoxic mechanisms, an intrinsic defect of melanocytes, oxidant-antioxidant mechanisms, and neural mechanisms. The pathogenesis is thought to involve an autoimmune process directed against melanocytes. Evidence of this is derived from histologic studies that have found an absence of melanocytes in the affected skin. An autoimmune process is also suggested by the concomitant occurrence of other autoimmune diseases in patients with vitiligo. Alterations in both cellular and humoral immunity have been reported. Evidence supports cellular immunity as an important factor in the development of vitiligo. CD8+ T cell predominant infiltrates have been found in perilesional skin and CD8+ cytotoxic T cells have been identified adjacent to disappearing melanocytes. Circulating melanocyte specific CD8+ cytotoxic T lymphocytes have been detected in the peripheral blood of patients with vitiligo, but it is unconfirmed whether these T cells correlate with those found in the skin . |